These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

653 related items for PubMed ID: 12190776

  • 1. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature.
    Hayreh SS, Zimmerman B, Kardon RH.
    Acta Ophthalmol Scand; 2002 Aug; 80(4):355-67. PubMed ID: 12190776
    [Abstract] [Full Text] [Related]

  • 2. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy.
    Hayreh SS, Zimmerman B.
    Ophthalmology; 2003 Jun; 110(6):1204-15. PubMed ID: 12799248
    [Abstract] [Full Text] [Related]

  • 3. Recovery of visual function in patients with biopsy-proven giant cell arteritis.
    Foroozan R, Deramo VA, Buono LM, Jayamanne DG, Sergott RC, Danesh-Meyer H, Savino PJ.
    Ophthalmology; 2003 Mar; 110(3):539-42. PubMed ID: 12623817
    [Abstract] [Full Text] [Related]

  • 4. Poor prognosis of visual outcome after visual loss from giant cell arteritis.
    Danesh-Meyer H, Savino PJ, Gamble GG.
    Ophthalmology; 2005 Jun; 112(6):1098-103. PubMed ID: 15885780
    [Abstract] [Full Text] [Related]

  • 5. Occult giant cell arteritis: ocular manifestations.
    Hayreh SS, Podhajsky PA, Zimmerman B.
    Am J Ophthalmol; 1998 Apr; 125(4):521-6. PubMed ID: 9559738
    [Abstract] [Full Text] [Related]

  • 6. Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management.
    Hayreh SS.
    Eye (Lond); 2004 Nov; 18(11):1188-206. PubMed ID: 15534605
    [Abstract] [Full Text] [Related]

  • 7. Anterior ischemic optic neuropathy due to giant cell arteritis with normal inflammatory markers.
    Yoeruek E, Szurman P, Tatar O, Weckerle P, Wilhelm H.
    Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):913-5. PubMed ID: 18386041
    [Abstract] [Full Text] [Related]

  • 8. Unilateral central retinal artery occlusion followed by contralateral anterior ischemic optic neuropathy in giant cell arteritis.
    Wein FB, Miller NR.
    Retina; 2000 Jun; 20(3):301-3. PubMed ID: 10872938
    [No Abstract] [Full Text] [Related]

  • 9. Simultaneous Bilateral Primary Occlusion of the Ophthalmic Artery due to Florid Giant Cell Arteritis.
    Berger T, Xanthopoulou K, Zemova E, Bohle RM, Seitz B, Abdin A.
    Klin Monbl Augenheilkd; 2022 Nov; 239(11):1369-1373. PubMed ID: 34380160
    [Abstract] [Full Text] [Related]

  • 10. Steroid management in giant cell arteritis.
    Chan CC, Paine M, O'Day J.
    Br J Ophthalmol; 2001 Sep; 85(9):1061-4. PubMed ID: 11520757
    [Abstract] [Full Text] [Related]

  • 11. An occult case of giant cell arteritis presenting with combined anterior ischemic optic neuropathy and cilioretinal artery occlusion.
    Galasso JM, Jay WM.
    Semin Ophthalmol; 2004 Sep; 19(3-4):75-7. PubMed ID: 15590540
    [Abstract] [Full Text] [Related]

  • 12. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision.
    Liu GT, Glaser JS, Schatz NJ, Smith JL.
    Ophthalmology; 1994 Nov; 101(11):1779-85. PubMed ID: 7800356
    [Abstract] [Full Text] [Related]

  • 13. Ocular vascular occlusive disorders: natural history of visual outcome.
    Hayreh SS.
    Prog Retin Eye Res; 2014 Jul; 41():1-25. PubMed ID: 24769221
    [Abstract] [Full Text] [Related]

  • 14. Progressive visual loss in a patient with presumed temporal arteritis despite treatment: how to make the diagnosis.
    Zborowska B, Ell J, McGhee-Collett M, Scolyer R, McCluskey PJ.
    Clin Exp Ophthalmol; 2004 Jun; 32(3):335-6. PubMed ID: 15180851
    [Abstract] [Full Text] [Related]

  • 15. Scalp necrosis with giant cell arteritis.
    Dudenhoefer EJ, Cornblath WT, Schatz MP.
    Ophthalmology; 1998 Oct; 105(10):1875-8. PubMed ID: 9787357
    [Abstract] [Full Text] [Related]

  • 16. Ocular manifestations of giant cell arteritis.
    Hayreh SS, Podhajsky PA, Zimmerman B.
    Am J Ophthalmol; 1998 Apr; 125(4):509-20. PubMed ID: 9559737
    [Abstract] [Full Text] [Related]

  • 17. Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone.
    Cornblath WT, Eggenberger ER.
    Ophthalmology; 1997 May; 104(5):854-8. PubMed ID: 9160034
    [Abstract] [Full Text] [Related]

  • 18. [Anterior ischemic optic neuropathy associated with giant cell arteritis. Case report].
    Obuchowska I, Mariak Z, Budrowski R.
    Klin Oczna; 2006 May; 108(1-3):124-7. PubMed ID: 16883958
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis of giant cell arteritis using clinical, laboratory, and histopathological findings in patients undergoing temporal artery biopsy.
    Muniz Castro HM, Bhattacharjee MB, Chaudhry IA, Chuang AZ, Mankiewicz KA, Adesina OO.
    Clin Neurol Neurosurg; 2022 Oct; 221():107377. PubMed ID: 35932586
    [Abstract] [Full Text] [Related]

  • 20. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies.
    Hayreh SS, Zimmerman B.
    Ophthalmologica; 2003 Oct; 217(4):239-59. PubMed ID: 12792130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.